ARTICLE | Company News
BioTime gene/cell therapy news
October 8, 2012 7:00 AM UTC
BioTime established a subsidiary, BioTime Acquisition Corp., to pursue opportunities and acquire assets and businesses in the fields of stem cells and regenerative medicine. BioTime hired Thomas Okarm...